Results 111 to 120 of about 14,393 (219)

Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients

open access: yesArthritis Research & Therapy
Background Lymph node (LN) studies in anti-cyclic citrullinated protein antibodies (ACPA) positive rheumatoid arthritis (RA) patients have revealed notable alterations in adaptive immune cell populations.
Aoife M. O’Byrne   +9 more
doaj   +1 more source

The women's college advantage: Research implications and practical lessons [PDF]

open access: yes, 2007
Presented at the 2007 ACPA-NASPA Joint Meeting in Orlando ...
Kinzie, J.   +3 more
core   +1 more source

Shaping deep approaches to learning on your campus [PDF]

open access: yes, 2007
Presented at the 2007 ACPA-NASPA Joint Meeting in Orlando ...
Niskode, A. S.   +4 more
core   +1 more source

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis

open access: yes, 2015
To understand the molecular features distinguishing anti-citrullinated protein antibodies (ACPA) from 'conventional' antibodies in rheumatoid arthritis (RA).
George M C Janssen   +37 more
core   +1 more source

Patient burden and joint inflammation during development of RA from arthralgia:is it similar in ACPA-positive and ACPA-negative disease? [PDF]

open access: yes
Objectives: ACPA-positive and ACPA-negative RA differ in underlying risk factors but have a similar clinical presentation at RA diagnosis. It is unknown what the ACPA-associated differences or similarities are during the symptomatic at-risk stage of RA ...
Krijbolder, Doortje   +9 more
core   +1 more source

Candidate autoantigens specifically bound to ACPA*.

open access: yes, 2016
Candidate autoantigens specifically bound to ACPA*.
Peyman Ezzati (353473)   +5 more
core   +1 more source

Metabolic reprogramming and macrophage expansion define ACPA-negative rheumatoid arthritis: insights from single-cell RNA sequencing

open access: yesFrontiers in Immunology
BackgroundAnti-citrullinated peptide antibodies (ACPA)-negative (ACPA−) rheumatoid arthritis (RA) presents significant diagnostic and therapeutic challenges due to the absence of specific biomarkers, underscoring the need to elucidate its distinctive ...
Yafeng Jiang   +6 more
doaj   +1 more source

ACPA-Induced ATP release and K+ efflux trigger NLRP3 inflammasome activation in rheumatoid arthritis

open access: yesCell Communication and Signaling
Objectives Anti-citrullinated protein antibodies (ACPA) is one of the key inducers of the initiation and maintenance of the immune-inflammatory response in Rheumatoid arthritis (RA), yet evidence is lacking on how ACPA drives the inflammatory response ...
Li Cai   +9 more
doaj   +1 more source

Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjects

open access: yesJournal of Translational Autoimmunity
Individuals with autoantibodies against citrullinated proteins (ACPA) and musculoskeletal symptoms face increased risk of developing rheumatoid arthritis (RA).
Klara Martinsson   +6 more
doaj   +1 more source

Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for developing rheumatoid arthritis

open access: yesArthritis Research & Therapy
Background Rheumatoid arthritis (RA) is typically preceded by an extended preclinical period where circulating autoantibodies, particularly anti-citrullinated protein antibodies (ACPA), are detectable in the absence of clinical arthritis.
Liam J. O’Neil   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy